Moleculin Biotech Inc (FRA:MOL)
€ 6.45 0 (0%) Market Cap: 6.66 Mil Enterprise Value: -3.07 Mil PE Ratio: 0 PB Ratio: 0.36 GF Score: 32/100

Moleculin Biotech Inc Participate in the Virtual Investor Ask the CEO Conference Transcript

Oct 24, 2023 / 04:00PM GMT
Release Date Price: €6.69 (-16.64%)
Jenene Thomas
JTCIR - Moderator

Okay, good afternoon and welcome back to the Virtual Investor Ask the CEO Event. My name is Jenene Thomas, I am CEO of JTCIR, and I will be the moderator for today's event. This is definitely a unique opportunity for investors to connect with management and for our next session, I am pleased to be joined by members of the Moleculin management teams. So we have Walter Klemp, CEO and Jon Foster, CFO. Welcome, gentlemen.

Walter Klemp
Moleculin Biotech Inc. - CEO

(multiple speakers) Glad to be here.

Jenene Thomas
JTCIR - Moderator

So glad to have you back. As a reminder, Moleculin is publicly listed on NASDAQ under the ticker MBRX. And during the discussion, the company will be making forward-looking statements and I encourage everyone to view the company's website and SEC filings for the latest information.

So as I said, Jon, I'm so happy to have you back on the virtual investor platform. As you know, we are hosting this event to give investor a platform of their own to ask

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot